Xenon Pharma
1 known investors
Xenon is a neuroscience company developing medicines for neurological and psychiatric conditions, with a late-stage investigational candidate, azetukalner, in development for epilepsy and depression. The company applies human genetics and ion channel biology to design compounds that target ion channels in the central and peripheral nervous systems.